salmeterol
Salmeterol is used for the treatment of moderate-to-severe persistent asthma. It is a long-acting β2 adrenergic receptor agonist (LABA) that acts as a bronchodilator. Salmeterol was first marketed and manufactured by Glaxo.Reference standards of Salmeterol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Salmeterol Xinafoate (IPRS/62/12)-from IPC
[catalogue_number] => PA IPIPRS 62 12
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] =>
[cas] => NA
[pslug] => salmeterol-xinafoate-iprs-62-12-paipiprs6212
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Salmeterol Xinafoate (IPRS/62/12)-from IPC
stdClass Object
(
[pname] => Salmeterol Xinafoate (IPRS/35/19)
[catalogue_number] => PA IPRS 35 19
[category_ids] => ,151,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => NA
[pslug] => salmeterol-xinafoate-iprs-35-19-paiprs3519
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Salmeterol Xinafoate (IPRS/35/19)
